WuXi Biologics (Cayman) Inc. (2269.HK)

HKD 24.1

(5.7%)

Inventory Summary of WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.'s latest annual inventory in 2023 was 1.76 Billion CNY , down -22.59% from previous year.
WuXi Biologics (Cayman) Inc.'s latest quarterly inventory in 2024 Q2 was 1.96 Billion CNY , down 0.0% from previous quarter.
WuXi Biologics (Cayman) Inc. reported annual inventory of 2.28 Billion CNY in 2022, up 35.18% from previous year.
WuXi Biologics (Cayman) Inc. reported annual inventory of 1.68 Billion CNY in 2021, up 55.63% from previous year.
WuXi Biologics (Cayman) Inc. reported quarterly inventory of 1.96 Billion CNY for 2024 Q1, up 11.15% from previous quarter.
WuXi Biologics (Cayman) Inc. reported quarterly inventory of 1.76 Billion CNY for 2023 FY, down -22.59% from previous quarter.

Annual Inventory Chart of WuXi Biologics (Cayman) Inc. (2023 - 2014)

Historical Annual Inventory of WuXi Biologics (Cayman) Inc. (2023 - 2014)

Year	Inventory	Inventory Growth
2023	1.76 Billion CNY	-22.59%
2022	2.28 Billion CNY	35.18%
2021	1.68 Billion CNY	55.63%
2020	1.08 Billion CNY	171.46%
2019	399.38 Million CNY	75.8%
2018	227.18 Million CNY	67.61%
2017	135.54 Million CNY	71.6%
2016	78.98 Million CNY	58.23%
2015	49.91 Million CNY	48.77%
2014	33.55 Million CNY	0.0%

Year	Inventory	Inventory Growth
2024 Q2	1.96 Billion CNY	0.0%
2024 Q1	1.96 Billion CNY	11.15%
2023 FY	1.76 Billion CNY	-22.59%
2023 Q3	1.76 Billion CNY	-10.15%
2023 Q4	1.76 Billion CNY	0.0%
2023 Q2	1.96 Billion CNY	0.0%
2023 Q1	1.96 Billion CNY	-13.84%
2022 Q3	2.28 Billion CNY	6.4%
2022 Q1	2.14 Billion CNY	27.05%
2022 FY	2.28 Billion CNY	35.18%
2022 Q4	2.28 Billion CNY	0.0%
2022 Q2	2.14 Billion CNY	0.0%
2021 Q3	1.68 Billion CNY	-1.14%
2021 FY	1.68 Billion CNY	55.63%
2021 Q1	1.7 Billion CNY	57.42%
2021 Q4	1.68 Billion CNY	0.0%
2021 Q2	1.7 Billion CNY	0.0%
2020 Q4	1.08 Billion CNY	0.0%
2020 FY	1.08 Billion CNY	171.46%
2020 Q1	611.76 Million CNY	53.17%
2020 Q2	611.76 Million CNY	0.0%
2020 Q3	1.08 Billion CNY	77.22%
2019 FY	399.38 Million CNY	75.8%
2019 Q4	399.38 Million CNY	0.0%
2019 Q3	399.38 Million CNY	25.22%
2019 Q2	318.94 Million CNY	0.0%
2019 Q1	318.94 Million CNY	40.39%
2018 Q1	243.33 Million CNY	79.52%
2018 Q4	227.18 Million CNY	0.0%
2018 Q3	227.18 Million CNY	-6.64%
2018 Q2	243.33 Million CNY	0.0%
2018 FY	227.18 Million CNY	67.61%
2017 Q1	239.5 Million CNY	203.22%
2017 FY	135.54 Million CNY	71.6%
2017 Q4	135.54 Million CNY	-59.89%
2017 Q3	337.93 Million CNY	268.96%
2017 Q2	91.59 Million CNY	-61.76%
2016 Q1	- CNY	-100.0%
2016 Q4	78.98 Million CNY	0.0%
2016 FY	78.98 Million CNY	58.23%
2015 Q4	150.54 Million CNY	0.0%
2015 FY	49.91 Million CNY	48.77%
2014 FY	33.55 Million CNY	0.0%

Peer Inventory Comparison of WuXi Biologics (Cayman) Inc.

Name	Inventory	Inventory Difference
Uni-Bio Science Group Limited	36.39 Million HKD	-4752.031%
CK Life Sciences Int'l., (Holdings) Inc.	1.2 Billion HKD	-46.592%